000137631 001__ 137631
000137631 005__ 20240109095554.0
000137631 0247_ $$2doi$$a10.1007/s00115-014-4088-5
000137631 0247_ $$2pmid$$apmid:25294667
000137631 0247_ $$2ISSN$$a0028-2804
000137631 0247_ $$2ISSN$$a1433-0407
000137631 037__ $$aDZNE-2020-03953
000137631 041__ $$ager
000137631 082__ $$a610
000137631 1001_ $$0P:(DE-HGF)0$$aHuber, M.$$b0$$eCorresponding author
000137631 245__ $$a[Drug safety: challenge in an aging society].
000137631 260__ $$aHeidelberg$$bSpringer$$c2014
000137631 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2014-10-09
000137631 264_1 $$2Crossref$$3print$$bSpringer Science and Business Media LLC$$c2014-11-01
000137631 3367_ $$2DRIVER$$aarticle
000137631 3367_ $$2DataCite$$aOutput Types/Journal article
000137631 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1704790479_29463
000137631 3367_ $$2BibTeX$$aARTICLE
000137631 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000137631 3367_ $$00$$2EndNote$$aJournal Article
000137631 520__ $$aWithin the context of the demographic change the proportion of the elderly in the overall population is steadily increasing. At the same time elderly patients are prescribed a disproportionately high number of medicines in comparison to younger patients. In the light of multimorbidity and polypharmacy which affect a relevant portion of the older population, drug safety is of particular importance.In recent years, the prescription of psychiatric drugs to elderly patients was repeatedly subjected to regulatory assessment and recommendations, for example the safety of antipsychotics in patients with dementia. As only limited information is often available with respect to the risks of medicines in the elderly population, additional efforts are necessary for improvement of the database. In this context, the system of spontaneous reporting, e.g. the reporting of cases of suspected adverse drug reactions to the responsible authorities, plays an important role with respect to the additional knowledge to be gathered. By reporting observed adverse drug reactions as well as by the quality of the reported information, physicians are able to significantly influence the effectiveness of this system in a positive way.As medical care for the majority of the elderly population is provided by general practitioners, adequate longitudinal studies are of special interest for investigating drug safety in the elderly. This aim is being pursued by the AgeCoDe study (German study on aging, cognition and dementia in primary care patients), a prospective, multicentre observational study, which is being carried out within the German competence network of degenerative dementia (Kompetenznetz Degenerative Demenzen).
000137631 536__ $$0G:(DE-HGF)POF3-345$$a345 - Population Studies and Genetics (POF3-345)$$cPOF3-345$$fPOF III$$x0
000137631 542__ $$2Crossref$$i2014-10-09$$uhttp://www.springer.com/tdm
000137631 588__ $$aDataset connected to CrossRef, PubMed,
000137631 650_7 $$2NLM Chemicals$$aAntipsychotic Agents
000137631 650_2 $$2MeSH$$aAdverse Drug Reaction Reporting Systems: organization & administration
000137631 650_2 $$2MeSH$$aAged
000137631 650_2 $$2MeSH$$aAged, 80 and over
000137631 650_2 $$2MeSH$$aAntipsychotic Agents: adverse effects
000137631 650_2 $$2MeSH$$aDrug Prescriptions: statistics & numerical data
000137631 650_2 $$2MeSH$$aDrug-Related Side Effects and Adverse Reactions: epidemiology
000137631 650_2 $$2MeSH$$aDrug-Related Side Effects and Adverse Reactions: etiology
000137631 650_2 $$2MeSH$$aDrug-Related Side Effects and Adverse Reactions: prevention & control
000137631 650_2 $$2MeSH$$aFemale
000137631 650_2 $$2MeSH$$aGermany: epidemiology
000137631 650_2 $$2MeSH$$aHumans
000137631 650_2 $$2MeSH$$aIncidence
000137631 650_2 $$2MeSH$$aMale
000137631 650_2 $$2MeSH$$aMandatory Reporting
000137631 650_2 $$2MeSH$$aMental Disorders: drug therapy
000137631 650_2 $$2MeSH$$aMental Disorders: epidemiology
000137631 650_2 $$2MeSH$$aRisk Assessment
000137631 650_2 $$2MeSH$$aRisk Factors
000137631 7001_ $$0P:(DE-HGF)0$$aBlumberg, A.$$b1
000137631 7001_ $$0P:(DE-HGF)0$$aChatterjee, S.$$b2
000137631 7001_ $$0P:(DE-2719)2810511$$aHänisch, Britta$$b3$$udzne
000137631 7001_ $$0P:(DE-HGF)0$$aSchlosser-Weber, G.$$b4
000137631 7001_ $$0P:(DE-HGF)0$$aBroich, K.$$b5
000137631 77318 $$2Crossref$$3journal-article$$a10.1007/s00115-014-4088-5$$b : Springer Science and Business Media LLC, 2014-10-09$$n11$$p1352-1362$$tDer Nervenarzt$$v85$$x0028-2804$$y2014
000137631 773__ $$0PERI:(DE-600)1462945-8$$a10.1007/s00115-014-4088-5$$gVol. 85, no. 11, p. 1352 - 1362$$n11$$p1352-1362$$q85:11<1352 - 1362$$tDer Nervenarzt$$v85$$x0028-2804$$y2014
000137631 8564_ $$uhttps://pub.dzne.de/record/137631/files/DZNE-2020-03953.pdf
000137631 8564_ $$uhttps://pub.dzne.de/record/137631/files/DZNE-2020-03953.pdf?subformat=pdfa$$xpdfa
000137631 909CO $$ooai:pub.dzne.de:137631$$pVDB
000137631 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810511$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000137631 9131_ $$0G:(DE-HGF)POF3-345$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vPopulation Studies and Genetics$$x0
000137631 9141_ $$y2014
000137631 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000137631 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNERVENARZT : 2017
000137631 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000137631 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000137631 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000137631 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000137631 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000137631 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000137631 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000137631 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000137631 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000137631 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000137631 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000137631 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000137631 9201_ $$0I:(DE-2719)1013010$$kAG Hänisch$$lPharmacoepidemiology$$x0
000137631 980__ $$ajournal
000137631 980__ $$aVDB
000137631 980__ $$aI:(DE-2719)1013010
000137631 980__ $$aUNRESTRICTED
000137631 999C5 $$2Crossref$$o
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/archinte.1997.00440350031003$$o10.1001/archinte.1997.00440350031003
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1370/afm.1337$$o10.1370/afm.1337
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1136/bmj.38330.470486.8F$$o10.1136/bmj.38330.470486.8F
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1176/appi.ajp.161.6.1113$$o10.1176/appi.ajp.161.6.1113
000137631 999C5 $$2Crossref$$oHolt 2010$$y2010
000137631 999C5 $$2Crossref$$oHuber 2013$$y2013
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1001/archgenpsychiatry.2010.30$$o10.1001/archgenpsychiatry.2010.30
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1371/journal.pone.0016852$$o10.1371/journal.pone.0016852
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1111/acps.12129$$o10.1111/acps.12129
000137631 999C5 $$2Crossref$$oMergel 2012$$y2012
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/978-3-642-37124-0_47$$o10.1007/978-3-642-37124-0_47
000137631 999C5 $$2Crossref$$oStammschulte 2010$$y2010
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jclinepi.2012.07.019$$o10.1016/j.jclinepi.2012.07.019
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1024/1011-6877.22.1.17$$o10.1024/1011-6877.22.1.17
000137631 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00103-013-1767-5$$o10.1007/s00103-013-1767-5